跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 184 条关于
“Valeris”
全部
184
临床试验
117
药物
26
机构
17
资讯
24
去年
Mercalis and PharmaCord Merge to Form Valeris, Creating Integrated Therapy Commercialization Platform
2年前
Vaderis' VAD044 Shows Promise in Hereditary Hemorrhagic Telangiectasia Trial
去年
Valerio Therapeutics Expands Antibody Development Capabilities with Emglev Therapeutics Acquisition
去年
Valerio Therapeutics Halts Clinical Trials, Pivots to Early-Stage Drug Development
去年
Vaderis' VAD044 Receives FDA Fast Track Designation for Hereditary Hemorrhagic Telangiectasia
2个月前
Vaderis Launches Global Phase 3 HEROIC Trial of Engasertib for Hereditary Hemorrhagic Telangiectasia
去年
Kalaris and AlloVir Complete Merger to Advance Novel Anti-VEGF Therapy for Retinal Diseases
2个月前
Valerio Therapeutics to Acquire Etherna Immunotherapies in €30M Deal, Creating Fully Integrated RNA Medicines Company
上个月
Vaderis Therapeutics Secures $152M Series B, Launches Phase 3 HEROIC Trial of Engasertib for HHT
去年
Allovir and Kalaris Therapeutics Merge to Focus on Retinal Disease Therapies
第 1 页,共 3 页
上一页
下一页